1. Hu, Yiyang, Gong, Chunli, Li, Zhibin, Yang, Shiming, Xiao, Yufeng. 2022. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification. In Molecular cancer, 21, 34. doi:10.1186/s12943-022-01522-y. https://pubmed.ncbi.nlm.nih.gov/35114989/
2. Wei, Cheng, Wang, Bo, Peng, Dazhao, Han, Lei, Zhang, Jianning. 2022. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas. In Frontiers in immunology, 13, 849592. doi:10.3389/fimmu.2022.849592. https://pubmed.ncbi.nlm.nih.gov/35444654/
3. Sun, Rui, Yuan, Lin, Jiang, Yi, Zhang, Lin, Cheng, Wenjun. 2023. ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer. In Theranostics, 13, 833-848. doi:10.7150/thno.77441. https://pubmed.ncbi.nlm.nih.gov/36632222/
4. Qiu, Xinyao, Yang, Shuai, Wang, Shan, Wang, Hong-Yang, Chen, Lei. 2021. M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma. In Cancer research, 81, 4778-4793. doi:10.1158/0008-5472.CAN-21-0468. https://pubmed.ncbi.nlm.nih.gov/34301762/